KR860005793A - 이미다졸 유도체와 그의 약학적 허용 가능한 에스테르, 아미드 및 염의 제조방법 - Google Patents

이미다졸 유도체와 그의 약학적 허용 가능한 에스테르, 아미드 및 염의 제조방법

Info

Publication number
KR860005793A
KR860005793A KR1019860000233A KR860000233A KR860005793A KR 860005793 A KR860005793 A KR 860005793A KR 1019860000233 A KR1019860000233 A KR 1019860000233A KR 860000233 A KR860000233 A KR 860000233A KR 860005793 A KR860005793 A KR 860005793A
Authority
KR
South Korea
Prior art keywords
sup
amides
salts
pharmaceutically acceptable
imidazole derivatives
Prior art date
Application number
KR1019860000233A
Other languages
English (en)
Other versions
KR930004674B1 (ko
Inventor
이사오 가마모또
로꾸로 엔도
게이이찌 마쓰다
시게루 우시야마
다께시 오시마
Original Assignee
상꾜 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 상꾜 가부시끼가이샤 filed Critical 상꾜 가부시끼가이샤
Publication of KR860005793A publication Critical patent/KR860005793A/ko
Application granted granted Critical
Publication of KR930004674B1 publication Critical patent/KR930004674B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
KR1019860000233A 1985-01-16 1986-01-16 이미다졸 유도체와 그의 약학적 허용 가능한 에스테르, 아미드 및 염의 제조방법 KR930004674B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP60-4055 1985-01-16
JP405585 1985-01-16

Publications (2)

Publication Number Publication Date
KR860005793A true KR860005793A (ko) 1986-08-13
KR930004674B1 KR930004674B1 (ko) 1993-06-03

Family

ID=11574190

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860000233A KR930004674B1 (ko) 1985-01-16 1986-01-16 이미다졸 유도체와 그의 약학적 허용 가능한 에스테르, 아미드 및 염의 제조방법

Country Status (13)

Country Link
US (1) US4894385A (ko)
EP (1) EP0188383B1 (ko)
JP (1) JPH0625141B2 (ko)
KR (1) KR930004674B1 (ko)
AT (1) ATE104967T1 (ko)
AU (1) AU582206B2 (ko)
CA (1) CA1296009C (ko)
DE (1) DE3689807T2 (ko)
DK (1) DK20886A (ko)
ES (2) ES8706125A1 (ko)
FI (1) FI90866C (ko)
NO (1) NO166445C (ko)
ZA (1) ZA86286B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960010343B1 (ko) * 1987-12-09 1996-07-30 에스에스 세이야꾸 가부시끼가이샤 이미다졸 유도체
US5308860A (en) * 1993-01-15 1994-05-03 Rohm And Haas Company Cyanosulfonylethyltriazoles
JP2002167378A (ja) 2000-09-22 2002-06-11 Ss Pharmaceut Co Ltd イミダゾール誘導体又はその塩
JP2006347882A (ja) * 2003-09-02 2006-12-28 Ss Pharmaceut Co Ltd ベンジルアルコール誘導体又はその塩

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0001654B1 (de) * 1977-10-13 1981-07-22 Siegfried Aktiengesellschaft Imidazolyläthyl-oxyalkoxy-Derivate und ihre Thio-Analoge, pharmazeutische Zubereitungen mit diesen Stoffen und Verfahren zu ihrer Herstellung
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体
DK471479A (da) * 1978-12-13 1980-06-14 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
JPS56120670A (en) * 1980-02-27 1981-09-22 Teijin Ltd 1-substituted imidazole derivative and its preparation
GB8400254D0 (en) * 1984-01-06 1984-02-08 Searle & Co Substituted alklidene imidazoles

Also Published As

Publication number Publication date
NO166445C (no) 1991-08-07
FI90866B (fi) 1993-12-31
AU582206B2 (en) 1989-03-16
EP0188383A2 (en) 1986-07-23
KR930004674B1 (ko) 1993-06-03
EP0188383A3 (en) 1988-06-22
FI860210A (fi) 1986-07-17
ES8801636A1 (es) 1988-02-16
FI860210A0 (fi) 1986-01-16
ES550972A0 (es) 1987-06-01
DK20886A (da) 1986-07-17
AU5242586A (en) 1986-07-24
ES557436A0 (es) 1988-02-16
JPH0625141B2 (ja) 1994-04-06
EP0188383B1 (en) 1994-04-27
JPS61267557A (ja) 1986-11-27
NO860114L (no) 1986-07-17
CA1296009C (en) 1992-02-18
DE3689807D1 (de) 1994-06-01
ATE104967T1 (de) 1994-05-15
US4894385A (en) 1990-01-16
ES8706125A1 (es) 1987-06-01
DE3689807T2 (de) 1994-08-25
FI90866C (fi) 1994-04-11
ZA86286B (en) 1986-09-24
DK20886D0 (da) 1986-01-16
NO166445B (no) 1991-04-15

Similar Documents

Publication Publication Date Title
ES8506677A1 (es) Un procedimiento para la preparacion de nuevos derivados de 8-cloro71,5-benzotiazepina.
IE790210L (en) Alkylenediamine derivatives
ES8704153A1 (es) Un procedimiento para preparar derivados de pirimidina
FI870373A0 (fi) Menetelmä lääkeaineina käyttökelpoisten dihydrotianaftaleeniyhdisteiden valmistamiseksi
KR860005793A (ko) 이미다졸 유도체와 그의 약학적 허용 가능한 에스테르, 아미드 및 염의 제조방법
EP0066909A3 (en) Imidazole derivatives, pharmaceutical compositions containing them and processes for their production
NZ216110A (en) 4-(z)-6-((2,4,5-cis -2-alkyl-4-(2-hydroxyphenyl)-1,3- dioxan-5-yl) hexenoic acid derivatives and pharmaceutical compositions
DE3685942D1 (de) 2-pyridylessigsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ES2006361A6 (es) Un procedimiento para preparar derivados de insoindolinilo opticamente activos.
ES8506620A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirrol-2-acetilaminoacido
HUT50461A (en) Process for producing imidazole derivatives inhibiting dopamin-beta-hydroxylase and pharmaceutical compositions comprising such compounds
ES8602789A1 (es) Procedimiento para preparar derivados de 14-hidroxiimino- eburnano racemicos y opticamente activos
ATE25584T1 (de) Verwendung von gamma-piperidino-butyrophenonen zu herstellung von arzneimitteln zum behandeln von diarrhoee.
MY104048A (en) New allylaminoethylazoles.
JPS5636414A (en) Anticonvulsant agent containing omega-aminoalkoxystilbene or its acid addition salt as active constituent
TH5201A (th) 7-((เมทา-ซับสทิทิวเตค) เฟนิลไกลซีน) 1-คาร์บา-1-ดีไธอะเซฟาโลสพอรินต่างๆ
ES464250A1 (es) Procedimiento de preparacion de nuevos esteres del acido isobutirico disustituido.

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee